Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Helleberg, H.
Right arrow Articles by Törnqvist, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helleberg, H.
Right arrow Articles by Törnqvist, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Mutagenesis, Vol. 16, No. 4, 333-337, July 2001
© 2001 UK Environmental Mutagen Society/Oxford University Press

Studies of dose distribution, premutagenic events and mutation frequencies for benzo[a]pyrene aiming at low dose cancer risk estimation

Hans Helleberg1,2, Honglan Xu1,5, Lars Ehrenberg1, Kari Hemminki4, Ulf Rannug1 and Margareta Törnqvist3,6

1 Department of Genetic and Cellular Toxicology, 2 Department of Molecular Genome Research and 3 Department of Environmental Chemistry, Stockholm University, S-106 91 Stockholm and 4 Unit for Molecular Epidemiology, Novum, Karolinska Institute, S-141 57 Huddinge, Sweden

Cancer risk assessment of polycyclic aromatic hydrocarbons (PAH) is complicated by several of these compounds exerting a promoter action leading to high tumour incidences at high doses. Cancer risks at low doses corresponding to the uptake from air and food in the general environment would best be estimated on the basis of measurement of in vivo target doses of genotoxic (mutagenic) intermediates and a determination of mutation frequency per unit of dose. In experiments ultimately aiming at a risk assessment of environmental PAH from in vivo doses benzo[a]pyrene (BaP) was chosen as a model. {gamma}-Radiation has earlier been used as a reference standard in cancer risk estimation of genotoxic chemicals where dose equivalents (rad-equivalents) have been shown to give reliable risk estimates for several alkylating agents. Variation in dose of BaP diolepoxide between organs was studied by measurement of deoxyguanosine-N2 adducts in DNA after administration of BaP by gavage to mice of a strain with reduced DNA repair (Xpa–/–). The adduct levels in spleen, forestomach, stomach and small intestine were approximately the same; with the adduct level in spleen as reference it was twice as high in liver and lung and about half as high in colon tissue. A chemical or radiation dose is proportional to the cumulative frequency of putatively premutagenic changes (premutagenic hits) in DNA. The mutation frequency per premutagenic hit (genotoxic chemicals) and per unit of dose ({gamma}-radiation) were calculated from acutely exposed V79 cells in order to determine the mutagenic effectiveness of each agent. Based on the mutagenic effectiveness determined in this study 10–4 Gy can be regarded equally effective in causing phenotypically expressed HPRT mutations as the dose of BaP which causes the formation of one deoxyguanosine-N2 adduct per cell.

5 Present address: China Institute for Radiation Protection, Taiyuan, Shanxi 030006, China

6 To whom correspondence should be addressed. Email: margareta.tornqvist{at}mk.su.se


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Anticancer ResHome page
W. B. GRANT
Air Pollution in Relation to U.S. Cancer Mortality Rates: An Ecological Study; Likely Role of Carbonaceous Aerosols and Polycyclic Aromatic Hydrocarbons
Anticancer Res, September 1, 2009; 29(9): 3537 - 3545.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
L. Godderis, P Aka, M Kirsch-Volders, and H Veulemans
Comparison of genotoxic potency of styrene 7,8-oxide with {gamma} radiation and human cancer risk estimation of styrene using the rad-equivalence approach
Mutagenesis, May 1, 2007; 22(3): 209 - 215.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
A. Ramesh, S. A. Walker, D. B. Hood, M. D. Guillen, K. Schneider, and E. H. Weyand
Bioavailability and Risk Assessment of Orally Ingested Polycyclic Aromatic Hydrocarbons
International Journal of Toxicology, September 1, 2004; 23(5): 301 - 333.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.